Polyceutix transforms cancer treatment by unleashing the full power of the immune system.
Polyceutix has raised $540K in total funding. The most recent round was Convertible Note. The last funding was announced in February 2024.
Polyceutix's investors include BioInnovation Institute.
Polyceutix is headquartered in Copenhagen, United States.
Polyceutix transforms cancer treatment by unleashing the full power of the immune system.
Polyceutix is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Polyceutix — Funding & Investors." VCBacked, February 29, 2024, https://www.vcbacked.co/company/polyceutix. Accessed August 16, 2026.
VCBacked. (2024). Polyceutix — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/polyceutix
{{cite web |title=Polyceutix — Funding & Investors |url=https://www.vcbacked.co/company/polyceutix |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated